SENSEONICS HOLDINGS INC (SENS)
US81727U1051 - Common Stock
Overall SENS gets a fundamental rating of 2 out of 10. We evaluated SENS against 187 industry peers in the Health Care Equipment & Supplies industry. The financial health of SENS is average, but there are quite some concerns on its profitability. While showing a medium growth rate, SENS is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
In the past year SENS has reported negative net income.
In the past year SENS has reported a negative cash flow from operations.
In the past 5 years SENS reported 4 times negative net income.
In the past 5 years SENS always reported negative operating cash flow.
1.2 Ratios
With a Return On Assets value of -58.12%, SENS is not doing good in the industry: 71.12% of the companies in the same industry are doing better.
SENS has a Return On Equity of -109.36%. This is in the lower half of the industry: SENS underperforms 65.24% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -58.12% | ||
| ROE | -109.36% | ||
| ROIC | N/A |
ROA(3y)-38.59%
ROA(5y)-138.09%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Profit Margin and Operating Margin and Gross Margin are not available for SENS so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
SENS does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, SENS has more shares outstanding
The number of shares outstanding for SENS has been increased compared to 5 years ago.
The debt/assets ratio for SENS has been reduced compared to a year ago.
2.2 Solvency
SENS has an Altman-Z score of -6.98. This is a bad value and indicates that SENS is not financially healthy and even has some risk of bankruptcy.
SENS's Altman-Z score of -6.98 is on the low side compared to the rest of the industry. SENS is outperformed by 74.33% of its industry peers.
SENS has a Debt/Equity ratio of 0.56. This is a neutral value indicating SENS is somewhat dependend on debt financing.
The Debt to Equity ratio of SENS (0.56) is worse than 65.24% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.56 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -6.98 |
ROIC/WACCN/A
WACC9.01%
2.3 Liquidity
A Current Ratio of 7.53 indicates that SENS has no problem at all paying its short term obligations.
SENS has a Current ratio of 7.53. This is amongst the best in the industry. SENS outperforms 87.70% of its industry peers.
SENS has a Quick Ratio of 7.03. This indicates that SENS is financially healthy and has no problem in meeting its short term obligations.
SENS's Quick ratio of 7.03 is amongst the best of the industry. SENS outperforms 89.30% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 7.53 | ||
| Quick Ratio | 7.03 |
3. Growth
3.1 Past
The earnings per share for SENS have decreased strongly by -30.00% in the last year.
SENS shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.41%.
Measured over the past years, SENS shows a small growth in Revenue. The Revenue has been growing by 3.43% on average per year.
EPS 1Y (TTM)-30%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)11.41%
Revenue growth 3Y65.39%
Revenue growth 5Y3.43%
Sales Q2Q%-30.08%
3.2 Future
The Earnings Per Share is expected to grow by 4.42% on average over the next years.
SENS is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 29.59% yearly.
EPS Next Y9.56%
EPS Next 2Y8.06%
EPS Next 3Y4.42%
EPS Next 5YN/A
Revenue Next Year1.64%
Revenue Next 2Y28.01%
Revenue Next 3Y29.59%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
SENS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SENS. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y8.06%
EPS Next 3Y4.42%
5. Dividend
5.1 Amount
No dividends for SENS!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
SENSEONICS HOLDINGS INC
NYSEARCA:SENS (12/20/2024, 8:04:00 PM)
After market: 0.46 +0 (+0.04%)0.4598
+0.02 (+4.03%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners10.99%
Inst Owner Change-0.12%
Ins Owners4.66%
Ins Owner Change-0.43%
Market Cap273.73M
Analysts50
Price Target1.43 (211%)
Short Float %7.32%
Short Ratio5.53
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-4.82%
Min EPS beat(2)-14%
Max EPS beat(2)4.35%
EPS beat(4)3
Avg EPS beat(4)5.47%
Min EPS beat(4)-14%
Max EPS beat(4)29.55%
EPS beat(8)4
Avg EPS beat(8)17.53%
EPS beat(12)7
Avg EPS beat(12)61.43%
EPS beat(16)8
Avg EPS beat(16)-129.69%
Revenue beat(2)1
Avg Revenue beat(2)-0.54%
Min Revenue beat(2)-3.55%
Max Revenue beat(2)2.48%
Revenue beat(4)3
Avg Revenue beat(4)2.89%
Min Revenue beat(4)-3.55%
Max Revenue beat(4)7.45%
Revenue beat(8)6
Avg Revenue beat(8)4.01%
Revenue beat(12)8
Avg Revenue beat(12)2.2%
Revenue beat(16)11
Avg Revenue beat(16)5.58%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)11.19%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-15.72%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 12.33 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 3.73 | ||
| P/tB | 3.73 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.13
EYN/A
EPS(NY)-0.12
Fwd EYN/A
FCF(TTM)-0.11
FCFYN/A
OCF(TTM)-0.1
OCFYN/A
SpS0.04
BVpS0.12
TBVpS0.12
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -58.12% | ||
| ROE | -109.36% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)-38.59%
ROA(5y)-138.09%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.16
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.56 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 176.58% | ||
| Cap/Sales | 10.7% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 7.53 | ||
| Quick Ratio | 7.03 | ||
| Altman-Z | -6.98 |
F-Score4
WACC9.01%
ROIC/WACCN/A
Cap/Depr(3y)25.34%
Cap/Depr(5y)39.26%
Cap/Sales(3y)1.67%
Cap/Sales(5y)2.71%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-30%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y9.56%
EPS Next 2Y8.06%
EPS Next 3Y4.42%
EPS Next 5YN/A
Revenue 1Y (TTM)11.41%
Revenue growth 3Y65.39%
Revenue growth 5Y3.43%
Sales Q2Q%-30.08%
Revenue Next Year1.64%
Revenue Next 2Y28.01%
Revenue Next 3Y29.59%
Revenue Next 5YN/A
EBIT growth 1Y-0.15%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year3.5%
EBIT Next 3Y6.54%
EBIT Next 5YN/A
FCF growth 1Y-4.16%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-0.92%
OCF growth 3YN/A
OCF growth 5YN/A